Table 4. Comparison of chemotherapy induced nausea control in both the groups as PDA versus OD group [n(%)].
Schedule | Acute phase (day 1) No. (%) | Delayed phase (day 2–5)* No. (%) | Overall response (day 1–5) No. (%) |
---|---|---|---|
No nausea | 21 (70%) versus | 23 (76.6%) versus | 21 (70%) versus |
14 (46.6%) | 13 (43.3%) | 13 (43.3%) | |
p = 0.06, NS** | p < 0.05, significant | p = 0.04, significant | |
Mild nausea (+) | 6 (20%) versus | 6 (20%) versus | 6 (20%) versus |
9 (30%) | 9 (30%) | 9 (30%) | |
p = 0.37, NS** | p = 0.37, NS** | p = 0.37, NS** | |
Moderate nausea (++) | 3 (10%) versus | 1 (3.3%) versus | 2 (6.7%) versus |
5 (16.6%) | 6 (20%) | 6 (20%) | |
p = 0.95, NS** | p = 0.44, NS** | p = 0.13, NS** | |
Severe nausea (+++) | 0 versus 2 (6.6%) | 0 versus 2 (6.6%) | 1 (3.3%) versus |
p = 0.15, NS** | p = 0.15, NS** | 2 (6.6%) | |
p = 0.55, NS** |
Delayed response is graded depending upon the worst response from day 2–5.
NS = Not significant